Phibro Animal Health Corporation Gain (Loss) Related to Litigation Settlement
Phibro Animal Health Corporation (PAHC) reported Gain (Loss) Related to Litigation Settlement of $3.56 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-26.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2026-08-26
- Phibro Animal Health Corporation gain (loss) related to litigation settlement for the quarter ending 2026-06-30 was -$223.00K, a 389.61% decline year-over-year.
- Phibro Animal Health Corporation gain (loss) related to litigation settlement for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Phibro Animal Health Corporation gain (loss) related to litigation settlement for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Phibro Animal Health Corporation gain (loss) related to litigation settlement for the quarter ending 2025-09-30 was $3.79M.
- Phibro Animal Health Corporation gain (loss) related to litigation settlement for fiscal 2026 was $3.56M, a 23.72% increase from fiscal 2025.
- Phibro Animal Health Corporation gain (loss) related to litigation settlement for fiscal 2025 was $2.88M, a 220.36% increase from fiscal 2024.
- Phibro Animal Health Corporation gain (loss) related to litigation settlement for fiscal 2024 was $899.00K.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-26 | -$223.00K derived: sum of 2 quarters · filed 2026-08-26 | -$223.00K derived: sum of 3 quarters · filed 2026-08-26 | $3.56M 10-K · filed 2026-08-26 |
| 2026-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $3.79M 10-Q · filed 2026-05-06 | $3.86M derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $3.79M 10-Q · filed 2026-02-04 | $3.86M derived: sum of 3 quarters · filed 2026-08-26 | $5.41M derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-09-30 | $3.79M 10-Q · filed 2025-11-05 | $3.86M derived: sum of 2 quarters · filed 2026-08-26 | $5.41M derived: sum of 3 quarters · filed 2026-08-26 | $6.67M derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-06-30 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-26 | $1.62M derived: sum of 2 quarters · filed 2026-08-26 | $2.88M derived: sum of 3 quarters · filed 2026-08-26 | $2.88M 10-K · filed 2026-08-26 |
| 2025-03-31 | $1.55M 10-Q · filed 2026-05-06 | $2.80M derived: sum of 2 quarters · filed 2026-05-06 | $2.80M 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $1.26M 10-Q · filed 2026-02-04 | $1.26M 10-Q · filed 2026-02-04 | ||
| 2024-06-30 | $625.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-26 | $899.00K derived: sum of 2 quarters · filed 2026-08-26 | $899.00K 10-K · filed 2026-08-26 | |
| 2024-03-31 | $274.00K 10-Q · filed 2025-05-07 | $274.00K 10-Q · filed 2025-05-07 |